CTX0E03

Unassigned

New Medicines

Disability following acute stroke

Information

Cell-based therapy (not an ATMP)
ReNeuron
ReNeuron

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Neural stem cells
Approximately 150,000 people suffer a stroke in the UK each year. Around one half of survivors are left with permanent disabilities as a result of the damage caused to brain tissue arising from the stroke. Beyond the acute phase, there are only preventative or rehabilitation measures [1].
Disability following acute stroke
Stereotactic
Parenteral